Charlotte Knights is an experienced professional who has worked in various roles including Director of Translational Biomarkers at Mission Therapeutics, Team Leader at KuDOS Pharmaceuticals, and Senior Scientist at the University of Cambridge. Charlotte holds a degree in Pharmacology from the University of Leeds and specializes in the discovery and development of small molecule inhibitors of DNA damage response within the field of oncology.
January 1, 2023 - present
January, 2021
September, 2010